Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis
Open Access
- 1 April 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (4) , 2192-2198
- https://doi.org/10.1128/iai.71.4.2192-2198.2003
Abstract
The use of DNA constructs encoding mycobacterial proteins is a promising new approach to vaccination against tuberculosis. A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been shown to protect against intravenous infection of mice with Mycobacterium tuberculosis in both the prophylactic and immunotherapeutic modes. It is shown here, however, that this vaccine was not effective in a more realistic aerosol infection model or in a model of latent tuberculosis in the lungs. Moreover, when given in an immunotherapeutic model the immunized mice developed classical Koch reactions characterized by multifocal discrete regions of cellular necrosis throughout the lung granulomas. Similar and equally severe reactions were seen in mice given a vaccine with DNA coding for the Ag85 antigen of M. tuberculosis. This previously unanticipated safety problem indicates that DNA vaccines should be used with caution in individuals who may have already been exposed to tuberculosis.Keywords
This publication has 28 references indexed in Scilit:
- DNA Immunization in a Mouse Model of Latent Tuberculosis: Effect of DNA Vaccination on Reactivation of Disease and on Reinfection with a Secondary ChallengeInfection and Immunity, 2002
- Mycobacterial Antigens Exacerbate Disease Manifestations inMycobacterium tuberculosis-Infected MiceInfection and Immunity, 2002
- Immunology of TuberculosisAnnual Review of Immunology, 2001
- Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule ofMycobacterium tuberculosisInfection and Immunity, 2000
- Transient Loss of Resistance to Pulmonary Tuberculosis in p47phox−/−MiceInfection and Immunity, 2000
- Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic ModeInfection and Immunity, 2000
- T Cell Response to Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1993
- Evaluation of the Protective Potency of New Tuberculosis VaccinesClinical Infectious Diseases, 1989
- Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64‐kDa proteinEuropean Journal of Immunology, 1987
- Fortsetzung der Mittheilungen über ein Heilmittel gegen TuberculoseDeutsche Medizinische Wochenschrift (1946), 1891